ClinicalTrials.Veeva

Menu

Sacral Nerve Modulation in IPAA Patients With Poor Function

U

University Hospital, Akershus

Status

Invitation-only

Conditions

Stoma Malfunction

Treatments

Device: Sacral nerve modulation

Study type

Interventional

Funder types

Other

Identifiers

NCT05730959
2014/2206

Details and patient eligibility

About

IPAA patients with poor functional outcome where no obvious reason can be detected are identified from our patient registry. These patients are offered a sacral nerve modulation test period of three weeks. They will then be scored on function and physiological testing will be done by a Barostat. After a another 14 days without stimulation the tests will be repeated. Those who respond positively will be offered permanent implantation of the Device..

Enrollment

22 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • UC With IPAA
  • Bad functional outcome

Exclusion criteria

  • Established treatable cause of malfunction

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

22 participants in 1 patient group

malfunctioning IPAA
Other group
Description:
Patients with malfunctioning IPAA
Treatment:
Device: Sacral nerve modulation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems